Article Details

Spero Therapeutics (SPRO) Receives $27.75 Consensus Price Target from Analysts

Retrieved on: 2018-05-15 23:58:39

Tags for this article:

Click the tags to see associated articles and topics

Spero Therapeutics (SPRO) Receives $27.75 Consensus Price Target from Analysts. View article details on HISWAI:

Excerpt

<div><b>Atlas Venture</b> Associates IX LLC bought a new stake in shares of Spero Therapeutics in the 4th quarter valued at about $16,179,000. California Public ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up